Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
ACE-2223 in Neurodegenerative Diseases: ACTRN12626000233325 Clinical Landscape Report 2026
16 September 2026
ACTRN12626000233325 clinical landscape for Neurodegenerative Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
Pociredir in Anemia, Sickle Cell: NCT07431398 Clinical Landscape Report 2026
16 September 2026
NCT07431398 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cemiplimab-RWLC in Gliosarcoma: NCT07422363 Clinical Landscape Report 2026
16 September 2026
NCT07422363 clinical landscape for Gliosarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
MUNC-CD34 in Acute Chest Syndrome: NCT07432867 Clinical Landscape Report 2026
16 September 2026
NCT07432867 clinical landscape for Acute Chest Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Spironolactone in Glioblastoma Multiforme: NCT07431216 Clinical Landscape Report 2026
16 September 2026
NCT07431216 clinical landscape for Glioblastoma Multiforme: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Temozolomide in Glioblastoma: NCT07439172 Clinical Landscape Report 2026
16 September 2026
NCT07439172 clinical landscape for Glioblastoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HW241045 in Idiopathic Pulmonary Fibrosis: NCT07448194 Clinical Landscape Report 2026
16 September 2026
NCT07448194 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pirfenidone in Idiopathic Pulmonary Fibrosis: NCT07454291 Clinical Landscape Report 2026
16 September 2026
NCT07454291 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Eribulin mesylate in Advanced Triple-Negative Breast Carcinoma: NCT07441512 Clinical Landscape Report 2026
16 September 2026
NCT07441512 clinical landscape for Advanced Triple-Negative Breast Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
Emicizumab in Hemophilic arthropathy: NCT07439055 Clinical Landscape Report 2026
16 September 2026
NCT07439055 clinical landscape for Hemophilic arthropathy: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
AFN-50 in Idiopathic Inflammatory Myopathies: NCT07448298 Clinical Landscape Report 2026
16 September 2026
NCT07448298 clinical landscape for Idiopathic Inflammatory Myopathies: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
FZ-AD005 in Glioblastoma, IDH-Wildtype: NCT07455045 Clinical Landscape Report 2026
16 September 2026
NCT07455045 clinical landscape for Glioblastoma, IDH-Wildtype: endpoints, sponsor, phase, geography, readouts, asset context and development white space.